Welcome to our dedicated page for Align Technology SEC filings (Ticker: ALGN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Invisalign case shipments, doctor adoption rates, and 3-D printing costs are buried deep inside Align Technology’s SEC filings. If you need to know when margins shift or executives trade stock, scrolling through hundreds of pages isn’t efficient.
Stock Titan decodes Align Technology SEC documents in real time. Our AI reads every 10-K and 10-Q the moment they hit EDGAR, then delivers concise explanations of clear-aligner revenue trends, iTero scanner growth, and supply-chain updates. Natural-language answers—like “Align Technology quarterly earnings report 10-Q filing” or “Align Technology proxy statement executive compensation”—surface instantly, so you spend minutes, not hours, extracting what matters.
All filing types are covered and linked to practical tasks investors run every day:
- Monitor Align Technology insider trading Form 4 transactions and receive Align Technology Form 4 insider transactions real-time alerts before markets open.
- Compare segment profitability with our summary of each Align Technology annual report 10-K simplified.
- Track Invisalign volume guidance via Align Technology 8-K material events explained.
- Dive into board pay packages inside the latest Align Technology proxy statement executive compensation.
Whether you’re understanding Align Technology SEC documents with AI or seeking quick Align Technology earnings report filing analysis, our platform translates technical language, highlights key risk factors, and flags footnotes that move the stock. Make decisions confidently with AI-powered summaries, expert commentary, and up-to-the-minute disclosure feeds—all in one place.
Align Technology (ALGN) Q2 2025 10-Q highlights:
- Revenue: $1.01 bn, -1.6% YoY; Clear Aligner -3.3%, Systems & Services +5.6%.
- Margin: Gross margin 70.0% (70.2% LY); operating margin 16.1% vs 14.3% on lower legal costs.
- Earnings: Net income $124.6 m (+29%), diluted EPS $1.72 (+34%). Six-month EPS $2.98 (+11%).
- Cash & Liquidity: Cash & equivalents $901 m (-14% YTD); no debt; operating cash flow $181 m (-4%).
- Capital return: Completed $1 bn Jan-23 buyback; repurchased 1.34 m shares for $225 m in H1; new $1 bn Apr-25 program with $200 m OMR slated for H2.
- Share count: 72.5 m outstanding (-3.5% YoY).
- Legal/one-offs: Recorded $4.2 m additional accrual toward $31.75 m Section-1 antitrust settlement (prelim approval 5/28/25); VAT dispute with UK HMRC refunded ~$100 m but subject to appeal.
- Segment profit: Clear Aligner op-profit $267 m (-11%); Systems & Services $86 m (+21%).
- Balance sheet: Inventories $243.8 m (-4% YTD); goodwill now $491 m after Cubicure acquisition.
- Tax: Effective rate 28.2% vs 32.9%.
Key takeaways: Despite modest top-line contraction, disciplined expense control, share buybacks and favorable other income drove double-digit EPS growth. Cash burn and continuing legal/tax uncertainties temper outlook, but new $1 bn authorization reinforces management’s confidence.
FAQ
What is the current stock price of Align Technology (ALGN)?
What is the market cap of Align Technology (ALGN)?
